Abstract
In this study we have identified the influence of Argovit on the immune system of mice after inhalation or intragastric or subcutaneous administration. Argovit is a preparation of polyvinylpyrrolidone-coated (43.6 ± 10.7 nm) silver nanoparticles. We have found no toxic effect on the immune cells and organs, changes in T- and B-lymphocytes quantity in the spleen, or proinflammatory cytokine production after exposure to silver nanoparticles through inhalation or intragastrically. The subcutaneous administration of silver nanoparticles has changed the ratio of lymphocyte subpopulations, increased the quantity of IFN-γ-producing T-lymphocytes 3.6-fold compared with the control, and increased the content of IFN-γ in the serum of mice to 125 ± 9.2 pg/mL compared to the control (74.5 ± 6.4 pg/mL).
Similar content being viewed by others
References
E. J. Coligan, Short Protocols in Immunology: a Compendium of Methods from Current Protocols in Immunology, Ed. by E. J. Coligan, E. B. Bierer, H. D. Margulies, E. M. Shevach, and W. Stroder (John Wiley and Sons, Hoboken, NJ, 2005).
W. H. De Jong, L. M. Van Der Ven, A. Sleijffers, M. V. D. Z. Park, E. H. J. M. Jansen, H. Van Loveren, and R. J. Vandebriel, “Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats,” Biomaterials 34(33), 8333–8343 (2013).
A. E. Hawley, S. S. Davis, and L. Illum, “Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics,” Adv. Drug Deliv. Rev. 17, 129–148 (1995).
M. Higuchi, A. Fokin, T. N. Masters, F. Robicsek, and G. W. Schmid-Schonbein, “Transport of colloidal particles in lymphatics and vasculature after subcutaneous injection,” J. Appl. Physiol. 86, 1381–1387 (1999).
F. Ikomi, G. K. Hanna, and G. W. Schmid-Schonbein, “Size- and surface-dependent uptake of colloid particles into the lymphatic system,” Lymphology 32, 90–102 (1999).
S. H. E. Kaufmann, Methods in Microbiology, Vol. 32: Immunology of Infection, Ed. by S. H. E. Kaufmann and D. Kabelitz, 2nd ed. (Acad. Press, London, 2002).
M. Korani, S. M. Rezayat, K. Gilani, BidgoliS. Arbabi, and S. Adeli, “Acute and subchronic dermal toxicity of nanosilver in guinea pig,” Int. J. Nanomed. 6, 855–862 (2011).
K. Loeschner, N. Hadrup, K. Qvortrup, A. Larsen, X. Gao, U. Vogel, A. Mortensen, H. Rye Lam, and E. H. Larsen, “Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate,” Part. Fibre Toxicol. 8(18) (2011). doi:10.1186/1743-8977-8-18
T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” J. Immunol. Methods 65(1–2), 55–63 (1983).
“Nanosilver: safety, health and environmental effects and role in antimicrobial resistance,” in Proc. 4th Plenary of Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (European Commission, Dec. 12, 2013).
K. C. Nguyen, V. L. Seligy, A. Massarsky, T. W. Moon, P. Rippstein, J. Tan, and A. F. Tayabali, “Comparison of toxicity of uncoated and coated silver nanoparticles,” J. Phys.: Conf. Ser. 429, 012025 (2013).
E. J. Park, E. Baeb, J. Yib, Y. Kimc, K. Choid, S. H. Leed, J. Yoond, B. C. Leed, and K. Park, “Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles,” Environ. Toxicol. Pharmacol. 30, 162–168 (2010).
R. Rustogi, J. Mill, J. F. Fraser, and R. M. Kimble, “The use of Acticoat TM in neonatal burns,” Burns 31, 878–882 (2005).
L. V. Stebounova, A. Adamcakova, J. S. Kim, H. Park, O’Shaughnessy P.T., V. H. Grassian and P. S. Thorne, “Nanosilver indiced minimal lung toxicity or inflammation in a subacute murine inhalation model,” Part. Fibre Toxicol. 8(5) (2011). doi:10.1186/1743-8977-8-5
J. Tang, L. Xiong, S. Wang, J. Wang, L. Liu, J. Li, F. Yuan, and T. Xi, “Distribution, translocation and accumulation of silver nanoparticles in rats,” J. Nanosci. Nanotechnol. 9(8), 4924–4932 (2009).
M. Van Der Zande, R. J. Vandebriel, E. Van Doren, E. Kramer, Z. Herrera Rivera, C. S. Serrano-Rojero, E. R. Gremmer, J. Mast, R. J. Peters, P. C. Hollman, P. J. Hendriksen, H. J. Marvin, A. A. Peijnenburg, and H. Bouwmeester, “Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure,” ACS Nano. 6 (8), 7427–7442 (2012).
S. W. P. Wijnhoven, W. J. G. M. Peijnenburg, C. A. A. Herberts, W. I. Hagens, A. G. Oomen, E. H. W. Heugens, B. Roszek, J. Bisschops, I. Gosens, D. Van De Meent, S. Dekkers, W. H. De Jong, M. Van Zijverden, A. J. A. M. Sips, and R. Geertsma, “Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment,” Nanotoxicology 3(2), 109–138 (2009).
S. C. Yah, S. G. Simate, and E. S. Iyuke, “Nanoparticles toxicity and their routes of exposures,” Pakistan J. Pharmaceut. Sci. 25(2), 477–491 (2012).
S. Zolnik Banu, A. Gonzalez-Fernandez, N. Sadrieh, and M. A. Dobrovolskai, “Minireview: nanoparticles and the immune system,” Endocrinology 151(2), 458–465 (2010).
Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animals Resources, Commission on Life Sciences, National Research Council, National Acad. Press, Washington, 1996).
A. A. Shumakova, V. V. Smirnova, O. N. Tananova, E. N. Trushina, L. V. Kravchenko, I. V. Aksenov, A. V. Selifanov, S. Kh. Soto, G. G. Kuznetsova, A. V. Bulakhov, I. V. Safenkova, I. V. Gmoshinskii, and S. A. Khotimchenko, “Toxicological-hygienic characteristics of silver nanoparticles injected into rat gastrointestinal tract,” Vopr. Pitaniya 80(6), 9–18 (2011).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © O.V. Kalmantaeva, V.V. Firstova, V.D. Potapov, E.V. Zyrina, V.N. Gerasimov, E.A. Ganina, V.A. Burmistrov, A.V. Borisov, 2014, published in Rossiiskie Nanotekhnologii, 2014, Vol. 9, Nos. 9–10.
Rights and permissions
About this article
Cite this article
Kalmantaeva, O.V., Firstova, V.V., Potapov, V.D. et al. Silver-nanoparticle exposure on immune system of mice depending on the route of administration. Nanotechnol Russia 9, 571–576 (2014). https://doi.org/10.1134/S1995078014050061
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1995078014050061